Page 43 of 189 pages LERONLIMAB as a CCR5 inhibito
Post# of 148126
(Total Views: 508)
Posted On: 04/22/2021 10:39:29 PM
Page 43 of 189 pages LERONLIMAB as a CCR5 inhibitor.
Talks about clinicals...either done/upcoming...when reading I found this rather interesting; "As of April 28, 2020...those that DiDn't qualify for the trials, received an EIND and became the beneficiary of the Drug through compassionate use THAT was REQUESTED for the patients.
Wonder how many didn't make the cut?...but ended up with the prize of Leronlimab anyway.
Do we have records of the recipients?
CAN we use the information?
What are the privacy issues?
What are we looking for?
Long-hauler symptoms?....or NOT
Talks about clinicals...either done/upcoming...when reading I found this rather interesting; "As of April 28, 2020...those that DiDn't qualify for the trials, received an EIND and became the beneficiary of the Drug through compassionate use THAT was REQUESTED for the patients.
Wonder how many didn't make the cut?...but ended up with the prize of Leronlimab anyway.
Do we have records of the recipients?
CAN we use the information?
What are the privacy issues?
What are we looking for?
Long-hauler symptoms?....or NOT
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼